<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34203830</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jun</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Role of Insulin in Health and Disease: An Update.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">6403</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22126403</ELocationID>
        <Abstract>
          <AbstractText>Insulin is a polypeptide hormone mainly secreted by Î² cells in the islets of Langerhans of the pancreas. The hormone potentially coordinates with glucagon to modulate blood glucose levels; insulin acts via an anabolic pathway, while glucagon performs catabolic functions. Insulin regulates glucose levels in the bloodstream and induces glucose storage in the liver, muscles, and adipose tissue, resulting in overall weight gain. The modulation of a wide range of physiological processes by insulin makes its synthesis and levels critical in the onset and progression of several chronic diseases. Although clinical and basic research has made significant progress in understanding the role of insulin in several pathophysiological processes, many aspects of these functions have yet to be elucidated. This review provides an update on insulin secretion and regulation, and its physiological roles and functions in different organs and cells, and implications to overall health. We cast light on recent advances in insulin-signaling targeted therapies, the protective effects of insulin signaling activators against disease, and recommendations and directions for future research.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rahman</LastName>
            <ForeName>Md Saidur</ForeName>
            <Initials>MS</Initials>
            <Identifier Source="ORCID">0000-0003-4583-8731</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Animal Science &amp; Technology and BET Research Institute, Chung-Ang University, Anseong 17546, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hossain</LastName>
            <ForeName>Khandkar Shaharina</ForeName>
            <Initials>KS</Initials>
            <Identifier Source="ORCID">0000-0002-9358-1523</Identifier>
            <AffiliationInfo>
              <Affiliation>ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Das</LastName>
            <ForeName>Sharnali</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kundu</LastName>
            <ForeName>Sushmita</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adegoke</LastName>
            <ForeName>Elikanah Olusayo</ForeName>
            <Initials>EO</Initials>
            <Identifier Source="ORCID">0000-0002-6896-9817</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Animal Science &amp; Technology and BET Research Institute, Chung-Ang University, Anseong 17546, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rahman</LastName>
            <ForeName>Md Ataur</ForeName>
            <Initials>MA</Initials>
            <Identifier Source="ORCID">0000-0001-6649-3694</Identifier>
            <AffiliationInfo>
              <Affiliation>ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hannan</LastName>
            <ForeName>Md Abdul</ForeName>
            <Initials>MA</Initials>
            <Identifier Source="ORCID">0000-0001-6640-4495</Identifier>
            <AffiliationInfo>
              <Affiliation>ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry and Molecular Biology, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uddin</LastName>
            <ForeName>Md Jamal</ForeName>
            <Initials>MJ</Initials>
            <Identifier Source="ORCID">0000-0003-2911-3255</Identifier>
            <AffiliationInfo>
              <Affiliation>ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Woman's University, Seoul 03760, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pang</LastName>
            <ForeName>Myung-Geol</ForeName>
            <Initials>MG</Initials>
            <Identifier Source="ORCID">0000-0003-2019-3789</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Animal Science &amp; Technology and BET Research Institute, Chung-Ang University, Anseong 17546, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004194" MajorTopicYN="Y">Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006262" MajorTopicYN="Y">Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000078790" MajorTopicYN="N">Insulin Secretion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">disease</Keyword>
        <Keyword MajorTopicYN="N">glucose</Keyword>
        <Keyword MajorTopicYN="N">health</Keyword>
        <Keyword MajorTopicYN="N">homeostasis</Keyword>
        <Keyword MajorTopicYN="N">insulin</Keyword>
        <Keyword MajorTopicYN="N">regulation</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>2</Day>
          <Hour>1</Hour>
          <Minute>18</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34203830</ArticleId>
        <ArticleId IdType="pmc">PMC8232639</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms22126403</ArticleId>
        <ArticleId IdType="pii">ijms22126403</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lewis G.F., Brubaker P.L. The discovery of insulin revisited: Lessons for the modern era. J. Clin. Investig. 2021;131:e142239. doi: 10.1172/JCI142239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI142239</ArticleId>
            <ArticleId IdType="pmc">PMC7773348</ArticleId>
            <ArticleId IdType="pubmed">33393501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vecchio I., Tornali C., Bragazzi N.L., Martini M. The Discovery of Insulin: An Important Milestone in the History of Medicine. Front. Endocrinol. 2018;9:613. doi: 10.3389/fendo.2018.00613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2018.00613</ArticleId>
            <ArticleId IdType="pmc">PMC6205949</ArticleId>
            <ArticleId IdType="pubmed">30405529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Csajbok E.A., Tamas G. Cerebral cortex: A target and source of insulin? Diabetologia. 2016;59:1609â1615. doi: 10.1007/s00125-016-3996-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-016-3996-2</ArticleId>
            <ArticleId IdType="pubmed">27207082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcon C., Lincoln B., Rhodes C.J. The biosynthesis of the subtilisin-related proprotein convertase PC3, but no that of the PC2 convertase, is regulated by glucose in parallel to proinsulin biosynthesis in rat pancreatic islets. J. Biol. Chem. 1993;268:4276â4280. doi: 10.1016/S0021-9258(18)53606-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9258(18)53606-1</ArticleId>
            <ArticleId IdType="pubmed">8440711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaufman B.A., Li C., Soleimanpour S.A. Mitochondrial regulation of beta-cell function: Maintaining the momentum for insulin release. Mol. Asp. Med. 2015;42:91â104. doi: 10.1016/j.mam.2015.01.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mam.2015.01.004</ArticleId>
            <ArticleId IdType="pmc">PMC4404204</ArticleId>
            <ArticleId IdType="pubmed">25659350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vasiljevic J., Torkko J.M., Knoch K.P., Solimena M. The making of insulin in health and disease. Diabetologia. 2020;63:1981â1989. doi: 10.1007/s00125-020-05192-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-020-05192-7</ArticleId>
            <ArticleId IdType="pmc">PMC7476993</ArticleId>
            <ArticleId IdType="pubmed">32894308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suckale J., Solimena M. The insulin secretory granule as a signaling hub. Trends Endocrinol. Metab. 2010;21:599â609. doi: 10.1016/j.tem.2010.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tem.2010.06.003</ArticleId>
            <ArticleId IdType="pubmed">20609596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang B.Y., Zhai G., Gong Y.L., Su J.Z., Peng X.Y., Shang G.H., Han D., Jin J.Y., Liu H.K., Du Z.Y., et al.  Different physiological roles of insulin receptors in mediating nutrient metabolism in zebrafish. Am. J. Physiol. Endocrinol. Metab. 2018;315:E38âE51. doi: 10.1152/ajpendo.00227.2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00227.2017</ArticleId>
            <ArticleId IdType="pubmed">29351486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avruch J. Insulin signal transduction through protein kinase cascades. Mol. Cell. Biochem. 1998;182:31â48. doi: 10.1023/A:1006823109415.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1006823109415</ArticleId>
            <ArticleId IdType="pubmed">9609112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: Insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006;7:85â96. doi: 10.1038/nrm1837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm1837</ArticleId>
            <ArticleId IdType="pubmed">16493415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Accili D. Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture. Diabetes. 2018;67:1701â1709. doi: 10.2337/dbi18-0025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dbi18-0025</ArticleId>
            <ArticleId IdType="pmc">PMC6110318</ArticleId>
            <ArticleId IdType="pubmed">30135131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davidovici B.B., Sattar N., Prinz J., Puig L., Emery P., Barker J.N., van de Kerkhof P., Stahle M., Nestle F.O., Girolomoni G., et al.  Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions. J. Investig. Dermatol. 2010;130:1785â1796. doi: 10.1038/jid.2010.103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/jid.2010.103</ArticleId>
            <ArticleId IdType="pubmed">20445552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plikus M.V., Van Spyk E.N., Pham K., Geyfman M., Kumar V., Takahashi J.S., Andersen B. The circadian clock in skin: Implications for adult stem cells, tissue regeneration, cancer, aging, and immunity. J. Biol. Rhythm. 2015;30:163â182. doi: 10.1177/0748730414563537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0748730414563537</ArticleId>
            <ArticleId IdType="pmc">PMC4441597</ArticleId>
            <ArticleId IdType="pubmed">25589491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baselga Torres E., Torres-Pradilla M. Cutaneous manifestations in children with diabetes mellitus and obesity. Actas Dermosifiliogr. 2014;105:546â557. doi: 10.1016/j.ad.2013.11.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ad.2013.11.014</ArticleId>
            <ArticleId IdType="pubmed">24698434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hough F.S., Pierroz D.D., Cooper C., Ferrari S.L., Bone I.C., Diabetes Working Group  Mechanisms in endocrinology: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur. J. Endocrinol. 2016;174:R127âR138. doi: 10.1530/EJE-15-0820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/EJE-15-0820</ArticleId>
            <ArticleId IdType="pubmed">26537861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirsch I.B., Juneja R., Beals J.M., Antalis C.J., Wright E.E. The Evolution of Insulin and How it Informs Therapy and Treatment Choices. Endocr. Rev. 2020;41:733â755. doi: 10.1210/endrev/bnaa015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/endrev/bnaa015</ArticleId>
            <ArticleId IdType="pmc">PMC7366348</ArticleId>
            <ArticleId IdType="pubmed">32396624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wendt A., Eliasson L. Pancreatic alpha-cellsâThe unsung heroes in islet function. Semin. Cell Dev. Biol. 2020;103:41â50. doi: 10.1016/j.semcdb.2020.01.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2020.01.006</ArticleId>
            <ArticleId IdType="pubmed">31983511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cabrera O., Berman D.M., Kenyon N.S., Ricordi C., Berggren P.O., Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. USA. 2006;103:2334â2339. doi: 10.1073/pnas.0510790103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0510790103</ArticleId>
            <ArticleId IdType="pmc">PMC1413730</ArticleId>
            <ArticleId IdType="pubmed">16461897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rorsman P., Braun M. Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol. 2013;75:155â179. doi: 10.1146/annurev-physiol-030212-183754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-physiol-030212-183754</ArticleId>
            <ArticleId IdType="pubmed">22974438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jansson L., Hellerstrom C. Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system. Am. J. Physiol. 1986;251:E644âE647. doi: 10.1152/ajpendo.1986.251.6.E644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.1986.251.6.E644</ArticleId>
            <ArticleId IdType="pubmed">3538897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu Z., Gilbert E.R., Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr. Diabetes Rev. 2013;9:25â53. doi: 10.2174/157339913804143225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/157339913804143225</ArticleId>
            <ArticleId IdType="pmc">PMC3934755</ArticleId>
            <ArticleId IdType="pubmed">22974359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Vos A., Heimberg H., Quartier E., Huypens P., Bouwens L., Pipeleers D., Schuit F. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J. Clin. Investig. 1995;96:2489â2495. doi: 10.1172/JCI118308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI118308</ArticleId>
            <ArticleId IdType="pmc">PMC185903</ArticleId>
            <ArticleId IdType="pubmed">7593639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCulloch L.J., van de Bunt M., Braun M., Frayn K.N., Clark A., Gloyn A.L. GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: Implications for understanding genetic association signals at this locus. Mol. Genet. Metab. 2011;104:648â653. doi: 10.1016/j.ymgme.2011.08.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymgme.2011.08.026</ArticleId>
            <ArticleId IdType="pubmed">21920790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gloyn A.L., Odili S., Zelent D., Buettger C., Castleden H.A., Steele A.M., Stride A., Shiota C., Magnuson M.A., Lorini R., et al.  Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J. Biol. Chem. 2005;280:14105â14113. doi: 10.1074/jbc.M413146200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M413146200</ArticleId>
            <ArticleId IdType="pubmed">15677479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doliba N.M., Qin W., Najafi H., Liu C., Buettger C.W., Sotiris J., Collins H.W., Li C., Stanley C.A., Wilson D.F., et al.  Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics. Am. J. Physiol. Endocrinol. Metab. 2012;302:E87âE102. doi: 10.1152/ajpendo.00218.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00218.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3328091</ArticleId>
            <ArticleId IdType="pubmed">21952036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yajima H., Komatsu M., Schermerhorn T., Aizawa T., Kaneko T., Nagai M., Sharp G.W., Hashizume K. cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes. 1999;48:1006â1012. doi: 10.2337/diabetes.48.5.1006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.48.5.1006</ArticleId>
            <ArticleId IdType="pubmed">10331404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada S., Komatsu M., Sato Y., Yamauchi K., Kojima I., Aizawa T., Hashizume K. Time-dependent stimulation of insulin exocytosis by 3â,5â-cyclic adenosine monophosphate in the rat islet beta-cell. Endocrinology. 2002;143:4203â4209. doi: 10.1210/en.2002-220368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2002-220368</ArticleId>
            <ArticleId IdType="pubmed">12399413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haeusler R.A., McGraw T.E., Accili D. Biochemical and cellular properties of insulin receptor signalling. Nat. Rev. Mol. Cell Biol. 2018;19:31â44. doi: 10.1038/nrm.2017.89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm.2017.89</ArticleId>
            <ArticleId IdType="pmc">PMC5894887</ArticleId>
            <ArticleId IdType="pubmed">28974775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saltiel A.R. Insulin signaling in health and disease. J. Clin. Investig. 2021;131:e142241. doi: 10.1172/JCI142241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI142241</ArticleId>
            <ArticleId IdType="pmc">PMC7773347</ArticleId>
            <ArticleId IdType="pubmed">33393497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burks D.J., White M.F. IRS proteins and beta-cell function. Diabetes. 2001;50(Suppl. 1):S140âS145. doi: 10.2337/diabetes.50.2007.S140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.50.2007.S140</ArticleId>
            <ArticleId IdType="pubmed">11272176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alves-Bezerra M., Cohen D.E. Triglyceride Metabolism in the Liver. Compr. Physiol. 2017;8:1â8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6376873</ArticleId>
            <ArticleId IdType="pubmed">29357123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatting M., Tavares C.D.J., Sharabi K., Rines A.K., Puigserver P. Insulin regulation of gluconeogenesis. Ann. NY Acad. Sci. 2018;1411:21â35. doi: 10.1111/nyas.13435.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/nyas.13435</ArticleId>
            <ArticleId IdType="pmc">PMC5927596</ArticleId>
            <ArticleId IdType="pubmed">28868790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adeyinka A., Kondamudi N.P.  StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2021. Hyperosmolar Hyperglycemic Nonketotic Coma.</Citation>
        </Reference>
        <Reference>
          <Citation>Gastaldelli A., Toschi E., Pettiti M., Frascerra S., Quinones-Galvan A., Sironi A.M., Natali A., Ferrannini E. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes. 2001;50:1807â1812. doi: 10.2337/diabetes.50.8.1807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.50.8.1807</ArticleId>
            <ArticleId IdType="pubmed">11473042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edgerton D.S., Lautz M., Scott M., Everett C.A., Stettler K.M., Neal D.W., Chu C.A., Cherrington A.D. Insulinâs direct effects on the liver dominate the control of hepatic glucose production. J. Clin. Investig. 2006;116:521â527. doi: 10.1172/JCI27073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI27073</ArticleId>
            <ArticleId IdType="pmc">PMC1359060</ArticleId>
            <ArticleId IdType="pubmed">16453026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girard J. Insulinâs effect on the liver: âdirect or indirect?â continues to be the question. J. Clin. Investig. 2006;116:302â304. doi: 10.1172/JCI27743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI27743</ArticleId>
            <ArticleId IdType="pmc">PMC1359064</ArticleId>
            <ArticleId IdType="pubmed">16453016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharabi K., Tavares C.D., Rines A.K., Puigserver P. Molecular pathophysiology of hepatic glucose production. Mol. Asp. Med. 2015;46:21â33. doi: 10.1016/j.mam.2015.09.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mam.2015.09.003</ArticleId>
            <ArticleId IdType="pmc">PMC4674831</ArticleId>
            <ArticleId IdType="pubmed">26549348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Claus T.H., Pilkis S.J. Regulation by insulin of gluconeogenesis in isolated rat hepatocytes. Biochim. Biophys. Acta. 1976;421:246â262. doi: 10.1016/0304-4165(76)90291-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0304-4165(76)90291-9</ArticleId>
            <ArticleId IdType="pubmed">175843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marks J.S., Botelho L.H. Synergistic inhibition of glucagon-induced effects on hepatic glucose metabolism in the presence of insulin and a cAMP antagonist. J. Biol. Chem. 1986;261:15895â15899. doi: 10.1016/S0021-9258(18)66648-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9258(18)66648-7</ArticleId>
            <ArticleId IdType="pubmed">3023331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindelar D.K., Balcom J.H., Chu C.A., Neal D.W., Cherrington A.D. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes. 1996;45:1594â1604. doi: 10.2337/diab.45.11.1594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diab.45.11.1594</ArticleId>
            <ArticleId IdType="pubmed">8866566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindelar D.K., Chu C.A., Venson P., Donahue E.P., Neal D.W., Cherrington A.D. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes. 1998;47:523â529. doi: 10.2337/diabetes.47.4.523.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.47.4.523</ArticleId>
            <ArticleId IdType="pubmed">9568682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito K., Maruyama H., Hirose H., Kido K., Koyama K., Kataoka K., Saruta T. Exogenous insulin dose-dependently suppresses glucopenia-induced glucagon secretion from perfused rat pancreas. Metabolism. 1995;44:358â362. doi: 10.1016/0026-0495(95)90166-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0026-0495(95)90166-3</ArticleId>
            <ArticleId IdType="pubmed">7885281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindelar D.K., Chu C.A., Rohlie M., Neal D.W., Swift L.L., Cherrington A.D. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes. 1997;46:187â196. doi: 10.2337/diab.46.2.187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diab.46.2.187</ArticleId>
            <ArticleId IdType="pubmed">9000693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obici S., Zhang B.B., Karkanias G., Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 2002;8:1376â1382. doi: 10.1038/nm1202-798.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1202-798</ArticleId>
            <ArticleId IdType="pubmed">12426561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergman R.N. Non-esterified fatty acids and the liver: Why is insulin secreted into the portal vein? Diabetologia. 2000;43:946â952. doi: 10.1007/s001250051474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s001250051474</ArticleId>
            <ArticleId IdType="pubmed">10952470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frontera W.R., Ochala J. Skeletal muscle: A brief review of structure and function. Calcif. Tissue Int. 2015;96:183â195. doi: 10.1007/s00223-014-9915-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00223-014-9915-y</ArticleId>
            <ArticleId IdType="pubmed">25294644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baron A.D., Brechtel G., Wallace P., Edelman S.V. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Pt 1Am. J. Physiol. 1988;255:E769âE774. doi: 10.1152/ajpendo.1988.255.6.E769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.1988.255.6.E769</ArticleId>
            <ArticleId IdType="pubmed">3059816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus. Med. Clin. N. Am. 2004;88:787â835. doi: 10.1016/j.mcna.2004.04.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mcna.2004.04.013</ArticleId>
            <ArticleId IdType="pubmed">15308380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeFronzo R.A. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667â687. doi: 10.2337/diab.37.6.667.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diab.37.6.667</ArticleId>
            <ArticleId IdType="pubmed">3289989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Defronzo R.A. Banting Lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773â795. doi: 10.2337/db09-9028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-9028</ArticleId>
            <ArticleId IdType="pmc">PMC2661582</ArticleId>
            <ArticleId IdType="pubmed">19336687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park S.W., Goodpaster B.H., Lee J.S., Kuller L.H., Boudreau R., de Rekeneire N., Harris T.B., Kritchevsky S., Tylavsky F.A., Nevitt M., et al.  Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009;32:1993â1997. doi: 10.2337/dc09-0264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc09-0264</ArticleId>
            <ArticleId IdType="pmc">PMC2768193</ArticleId>
            <ArticleId IdType="pubmed">19549734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdulla H., Smith K., Atherton P.J., Idris I. Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: A systematic review and meta-analysis. Diabetologia. 2016;59:44â55. doi: 10.1007/s00125-015-3751-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-015-3751-0</ArticleId>
            <ArticleId IdType="pubmed">26404065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romijn J.A., Coyle E.F., Sidossis L.S., Gastaldelli A., Horowitz J.F., Endert E., Wolfe R.R. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Pt 1Am. J. Physiol. 1993;265:E380âE391. doi: 10.1152/ajpendo.1993.265.3.E380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.1993.265.3.E380</ArticleId>
            <ArticleId IdType="pubmed">8214047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi M., Yoshida H. Endoplasmic reticulum stress in kidney function and disease. Curr. Opin. Nephrol. Hypertens. 2015;24:345â350. doi: 10.1097/MNH.0000000000000141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MNH.0000000000000141</ArticleId>
            <ArticleId IdType="pubmed">26050121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng A., Dube N., Gu F., Tremblay M.L. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur. J. Biochem. 2002;269:1050â1059. doi: 10.1046/j.0014-2956.2002.02756.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.0014-2956.2002.02756.x</ArticleId>
            <ArticleId IdType="pubmed">11856336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karakelides H., Asmann Y.W., Bigelow M.L., Short K.R., Dhatariya K., Coenen-Schimke J., Kahl J., Mukhopadhyay D., Nair K.S. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes. 2007;56:2683â2689. doi: 10.2337/db07-0378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db07-0378</ArticleId>
            <ArticleId IdType="pubmed">17660267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birsoy K., Festuccia W.T., Laplante M. A comparative perspective on lipid storage in animals. Pt 7J. Cell Sci. 2013;126:1541â1552. doi: 10.1242/jcs.104992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.104992</ArticleId>
            <ArticleId IdType="pubmed">23658371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gesta S., Tseng Y.H., Kahn C.R. Developmental origin of fat: Tracking obesity to its source. Cell. 2007;131:242â256. doi: 10.1016/j.cell.2007.10.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2007.10.004</ArticleId>
            <ArticleId IdType="pubmed">17956727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith U. Impaired (âdiabeticâ) insulin signaling and action occur in fat cells long before glucose intolerance--is insulin resistance initiated in the adipose tissue? Int. J. Obes. Relat. Metab. Disord. 2002;26:897â904. doi: 10.1038/sj.ijo.0802028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ijo.0802028</ArticleId>
            <ArticleId IdType="pubmed">12080441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cignarelli A., Genchi V.A., Perrini S., Natalicchio A., Laviola L., Giorgino F. Insulin and Insulin Receptors in Adipose Tissue Development. Int. J. Mol. Sci. 2019;20:759.  doi: 10.3390/ijms20030759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20030759</ArticleId>
            <ArticleId IdType="pmc">PMC6387287</ArticleId>
            <ArticleId IdType="pubmed">30754657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koyama K., Chen G., Lee Y., Unger R.H. Tissue triglycerides, insulin resistance, and insulin production: Implications for hyperinsulinemia of obesity. Am. J. Physiol. 1997;273:E708âE713. doi: 10.1152/ajpendo.1997.273.4.E708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.1997.273.4.E708</ArticleId>
            <ArticleId IdType="pubmed">9357799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Favero G., Paganelli C., Buffoli B., Rodella L.F., Rezzani R. Endothelium and its alterations in cardiovascular diseases: Life style intervention. BioMed Res. Int. 2014;2014:801896. doi: 10.1155/2014/801896.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/801896</ArticleId>
            <ArticleId IdType="pmc">PMC3955677</ArticleId>
            <ArticleId IdType="pubmed">24719887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barac A., Campia U., Panza J.A. Methods for evaluating endothelial function in humans. Hypertension. 2007;49:748â760. doi: 10.1161/01.HYP.0000259601.38807.a6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.HYP.0000259601.38807.a6</ArticleId>
            <ArticleId IdType="pubmed">17309954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muniyappa R., Quon M.J. Insulin action and insulin resistance in vascular endothelium. Curr. Opin. Clin. Nutr. Metab. Care. 2007;10:523â530. doi: 10.1097/MCO.0b013e32819f8ecd.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MCO.0b013e32819f8ecd</ArticleId>
            <ArticleId IdType="pubmed">17563474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vicent D., Ilany J., Kondo T., Naruse K., Fisher S.J., Kisanuki Y.Y., Bursell S., Yanagisawa M., King G.L., Kahn C.R. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Investig. 2003;111:1373â1380. doi: 10.1172/JCI15211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI15211</ArticleId>
            <ArticleId IdType="pmc">PMC154437</ArticleId>
            <ArticleId IdType="pubmed">12727929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potenza M.A., Addabbo F., Montagnani M. Vascular actions of insulin with implications for endothelial dysfunction. Am. J. Physiol. Endocrinol. Metab. 2009;297:E568âE577. doi: 10.1152/ajpendo.00297.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00297.2009</ArticleId>
            <ArticleId IdType="pubmed">19491294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hom F.G., Goodner C.J., Berrie M.A. A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain. Diabetes. 1984;33:141â152. doi: 10.2337/diab.33.2.141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diab.33.2.141</ArticleId>
            <ArticleId IdType="pubmed">6363168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasselbalch S.G., Knudsen G.M., Videbaek C., Pinborg L.H., Schmidt J.F., Holm S., Paulson O.B. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes. 1999;48:1915â1921. doi: 10.2337/diabetes.48.10.1915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.48.10.1915</ArticleId>
            <ArticleId IdType="pubmed">10512354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Havrankova J., Schmechel D., Roth J., Brownstein M. Identification of insulin in rat brain. Proc. Natl. Acad. Sci. USA. 1978;75:5737â5741. doi: 10.1073/pnas.75.11.5737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.75.11.5737</ArticleId>
            <ArticleId IdType="pmc">PMC393044</ArticleId>
            <ArticleId IdType="pubmed">364489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramnanan C.J., Edgerton D.S., Cherrington A.D. Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production. Cell Metab. 2012;15:656â664. doi: 10.1016/j.cmet.2012.03.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2012.03.006</ArticleId>
            <ArticleId IdType="pmc">PMC3348512</ArticleId>
            <ArticleId IdType="pubmed">22560218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramnanan C.J., Kraft G., Smith M.S., Farmer B., Neal D., Williams P.E., Lautz M., Farmer T., Donahue E.P., Cherrington A.D., et al.  Interaction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog. Diabetes. 2013;62:74â84. doi: 10.2337/db12-0148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db12-0148</ArticleId>
            <ArticleId IdType="pmc">PMC3526039</ArticleId>
            <ArticleId IdType="pubmed">23011594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benedict C., Hallschmid M., Schultes B., Born J., Kern W. Intranasal insulin to improve memory function in humans. Neuroendocrinology. 2007;86:136â142. doi: 10.1159/000106378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000106378</ArticleId>
            <ArticleId IdType="pubmed">17643054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Craft S., Baker L.D., Montine T.J., Minoshima S., Watson G.S., Claxton A., Arbuckle M., Callaghan M., Tsai E., Plymate S.R., et al.  Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Arch. Neurol. 2012;69:29â38. doi: 10.1001/archneurol.2011.233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneurol.2011.233</ArticleId>
            <ArticleId IdType="pmc">PMC3260944</ArticleId>
            <ArticleId IdType="pubmed">21911655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taouis M., Torres-Aleman I. Editorial: Insulin and The Brain. Front. Endocrinol. 2019;10:299. doi: 10.3389/fendo.2019.00299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2019.00299</ArticleId>
            <ArticleId IdType="pmc">PMC6524151</ArticleId>
            <ArticleId IdType="pubmed">31133989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benedict C., Kern W., Schultes B., Born J., Hallschmid M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J. Clin. Endocrinol. Metab. 2008;93:1339â1344. doi: 10.1210/jc.2007-2606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2007-2606</ArticleId>
            <ArticleId IdType="pubmed">18230654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kern W., Benedict C., Schultes B., Plohr F., Moser A., Born J., Fehm H.L., Hallschmid M. Low cerebrospinal fluid insulin levels in obese humans. Diabetologia. 2006;49:2790â2792. doi: 10.1007/s00125-006-0409-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-006-0409-y</ArticleId>
            <ArticleId IdType="pubmed">16951936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitmer R.A., Gunderson E.P., Barrett-Connor E., Quesenberry C.P., Jr., Yaffe K. Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ. 2005;330:1360. doi: 10.1136/bmj.38446.466238.E0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.38446.466238.E0</ArticleId>
            <ArticleId IdType="pmc">PMC558283</ArticleId>
            <ArticleId IdType="pubmed">15863436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benedict C., Hallschmid M., Hatke A., Schultes B., Fehm H.L., Born J., Kern W. Intranasal insulin improves memory in humans. Psychoneuroendocrinology. 2004;29:1326â1334. doi: 10.1016/j.psyneuen.2004.04.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psyneuen.2004.04.003</ArticleId>
            <ArticleId IdType="pubmed">15288712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunner Y.F., Kofoet A., Benedict C., Freiherr J. Central insulin administration improves odor-cued reactivation of spatial memory in young men. J. Clin. Endocrinol. Metab. 2015;100:212â219. doi: 10.1210/jc.2014-3018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2014-3018</ArticleId>
            <ArticleId IdType="pubmed">25337926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reger M.A., Watson G.S., Frey W.H., 2nd, Baker L.D., Cholerton B., Keeling M.L., Belongia D.A., Fishel M.A., Plymate S.R., Schellenberg G.D., et al.  Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype. Neurobiol. Aging. 2006;27:451â458. doi: 10.1016/j.neurobiolaging.2005.03.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2005.03.016</ArticleId>
            <ArticleId IdType="pubmed">15964100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reger M.A., Watson G.S., Green P.S., Wilkinson C.W., Baker L.D., Cholerton B., Fishel M.A., Plymate S.R., Breitner J.C., DeGroodt W., et al.  Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 2008;70:440â448. doi: 10.1212/01.WNL.0000265401.62434.36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/01.WNL.0000265401.62434.36</ArticleId>
            <ArticleId IdType="pubmed">17942819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hallschmid M., Benedict C., Born J., Fehm H.L., Kern W. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man. Physiol. Behav. 2004;83:55â64. doi: 10.1016/S0031-9384(04)00349-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0031-9384(04)00349-X</ArticleId>
            <ArticleId IdType="pubmed">15501491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farber S.J., Berger E.Y., Earle D.P. Effect of diabetes and insulin of the maximum capacity of the renal tubules to reabsorb glucose. J. Clin. Investig. 1951;30:125â129. doi: 10.1172/JCI102424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI102424</ArticleId>
            <ArticleId IdType="pmc">PMC436236</ArticleId>
            <ArticleId IdType="pubmed">14814204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh S., Sharma R., Kumari M., Tiwari S. Insulin receptors in the kidneys in health and disease. World J. Nephrol. 2019;8:11â22. doi: 10.5527/wjn.v8.i1.11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5527/wjn.v8.i1.11</ArticleId>
            <ArticleId IdType="pmc">PMC6354081</ArticleId>
            <ArticleId IdType="pubmed">30705868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gatica R., Bertinat R., Silva P., Carpio D., Ramirez M.J., Slebe J.C., San Martin R., Nualart F., Campistol J.M., Caelles C., et al.  Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney. J. Cell. Biochem. 2013;114:639â649. doi: 10.1002/jcb.24406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.24406</ArticleId>
            <ArticleId IdType="pubmed">23059533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tiwari S., Halagappa V.K., Riazi S., Hu X., Ecelbarger C.A. Reduced expression of insulin receptors in the kidneys of insulin-resistant rats. J. Am. Soc. Nephrol. 2007;18:2661â2671. doi: 10.1681/ASN.2006121410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2006121410</ArticleId>
            <ArticleId IdType="pubmed">17855644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winzell M.S., Ahren B. The high-fat diet-fed mouse: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 2004;53(Suppl. 3):S215âS219. doi: 10.2337/diabetes.53.suppl_3.S215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.53.suppl_3.S215</ArticleId>
            <ArticleId IdType="pubmed">15561913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Underwood P.C., Adler G.K. The renin angiotensin aldosterone system and insulin resistance in humans. Curr. Hypertens. Rep. 2013;15:59â70. doi: 10.1007/s11906-012-0323-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11906-012-0323-2</ArticleId>
            <ArticleId IdType="pmc">PMC3551270</ArticleId>
            <ArticleId IdType="pubmed">23242734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Csibi A., Communi D., Muller N., Bottari S.P. Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS ONE. 2010;5:e10070.  doi: 10.1371/journal.pone.0010070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0010070</ArticleId>
            <ArticleId IdType="pmc">PMC2850936</ArticleId>
            <ArticleId IdType="pubmed">20383279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akhtar M., Taha N.M., Nauman A., Mujeeb I.B., Al-Nabet A. Diabetic Kidney Disease: Past and Present. Adv. Anat. Pathol. 2020;27:87â97. doi: 10.1097/PAP.0000000000000257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PAP.0000000000000257</ArticleId>
            <ArticleId IdType="pubmed">31876542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malekzadeh B.O., Erlandsson M.C., Tengvall P., Palmquist A., Ransjo M., Bokarewa M.I., Westerlund A. Effects of implant-delivered insulin on bone formation in osteoporotic rats. J. Biomed. Mater. Res. A. 2018;106:2472â2480. doi: 10.1002/jbm.a.36442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbm.a.36442</ArticleId>
            <ArticleId IdType="pubmed">29673097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fulzele K., Riddle R.C., DiGirolamo D.J., Cao X., Wan C., Chen D., Faugere M.C., Aja S., Hussain M.A., Bruning J.C., et al.  Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142:309â319. doi: 10.1016/j.cell.2010.06.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2010.06.002</ArticleId>
            <ArticleId IdType="pmc">PMC2925155</ArticleId>
            <ArticleId IdType="pubmed">20655471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thrailkill K.M., Lumpkin C.K., Jr., Bunn R.C., Kemp S.F., Fowlkes J.L. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am. J. Physiol. Endocrinol. Metab. 2005;289:E735âE745. doi: 10.1152/ajpendo.00159.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00159.2005</ArticleId>
            <ArticleId IdType="pmc">PMC2387001</ArticleId>
            <ArticleId IdType="pubmed">16215165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Y., Woo W.M., Nagao K., Li W., Terunuma A., Mukouyama Y.S., Oro A.E., Vogel J.C., Brownell I. Perivascular hair follicle stem cells associate with a venule annulus. J. Investig. Dermatol. 2013;133:2324â2331. doi: 10.1038/jid.2013.167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/jid.2013.167</ArticleId>
            <ArticleId IdType="pmc">PMC3742722</ArticleId>
            <ArticleId IdType="pubmed">23558405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Correll C.U., Robinson D.G., Schooler N.R., Brunette M.F., Mueser K.T., Rosenheck R.A., Marcy P., Addington J., Estroff S.E., Robinson J., et al.  Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: Baseline results from the RAISE-ETP study. JAMA Psychiatry. 2014;71:1350â1363. doi: 10.1001/jamapsychiatry.2014.1314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2014.1314</ArticleId>
            <ArticleId IdType="pubmed">25321337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierard G.E., Seite S., Hermanns-Le T., Delvenne P., Scheen A., Pierard-Franchimont C. The skin landscape in diabetes mellitus. Focus on dermocosmetic management. Clin. Cosmet. Investig. Dermatol. 2013;6:127â135. doi: 10.2147/CCID.S43141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S43141</ArticleId>
            <ArticleId IdType="pmc">PMC3658433</ArticleId>
            <ArticleId IdType="pubmed">23696712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Napolitano M., Megna M., Monfrecola G. Insulin resistance and skin diseases. Sci. World J. 2015;2015:479354. doi: 10.1155/2015/479354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2015/479354</ArticleId>
            <ArticleId IdType="pmc">PMC4419263</ArticleId>
            <ArticleId IdType="pubmed">25977937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahana M., Grossman E., Feinstein A., Ronnen M., Cohen M., Millet M.S. Skin tags: A cutaneous marker for diabetes mellitus. Acta Derm. Venereol. 1987;67:175â177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2438887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cordain L., Lindeberg S., Hurtado M., Hill K., Eaton S.B., Brand-Miller J. Acne vulgaris: A disease of Western civilization. Arch. Dermatol. 2002;138:1584â1590. doi: 10.1001/archderm.138.12.1584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archderm.138.12.1584</ArticleId>
            <ArticleId IdType="pubmed">12472346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindeberg S., Eliasson M., Lindahl B., Ahren B. Low serum insulin in traditional Pacific Islanders--the Kitava Study. Metabolism. 1999;48:1216â1219. doi: 10.1016/S0026-0495(99)90258-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0026-0495(99)90258-5</ArticleId>
            <ArticleId IdType="pubmed">10535381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melnik B.C., John S.M., Schmitz G. Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: Lessons learnt from laron syndrome. Nutr. Metab. 2011;8:41. doi: 10.1186/1743-7075-8-41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1743-7075-8-41</ArticleId>
            <ArticleId IdType="pmc">PMC3141390</ArticleId>
            <ArticleId IdType="pubmed">21699736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toussirot E., Aubin F., Dumoulin G. Relationships between Adipose Tissue and Psoriasis, with or without Arthritis. Front. Immunol. 2014;5:368. doi: 10.3389/fimmu.2014.00368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2014.00368</ArticleId>
            <ArticleId IdType="pmc">PMC4129363</ArticleId>
            <ArticleId IdType="pubmed">25161652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yadav A., Kataria M.A., Saini V., Yadav A. Role of leptin and adiponectin in insulin resistance. Clin. Chim. Acta. 2013;417:80â84. doi: 10.1016/j.cca.2012.12.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cca.2012.12.007</ArticleId>
            <ArticleId IdType="pubmed">23266767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdel Hay R.M., Rashed L.A. Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis. Exp. Dermatol. 2011;20:715â719. doi: 10.1111/j.1600-0625.2011.01299.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-0625.2011.01299.x</ArticleId>
            <ArticleId IdType="pubmed">21569107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coimbra S., Oliveira H., Reis F., Belo L., Rocha S., Quintanilha A., Figueiredo A., Teixeira F., Castro E., Rocha-Pereira P., et al.  Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J. Eur. Acad. Dermatol. Venereol. 2010;24:1386â1394. doi: 10.1111/j.1468-3083.2010.03647.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-3083.2010.03647.x</ArticleId>
            <ArticleId IdType="pubmed">20337818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruegsegger G.N., Creo A.L., Cortes T.M., Dasari S., Nair K.S. Altered mitochondrial function in insulin-deficient and insulin-resistant states. J. Clin. Investig. 2018;128:3671â3681. doi: 10.1172/JCI120843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI120843</ArticleId>
            <ArticleId IdType="pmc">PMC6118582</ArticleId>
            <ArticleId IdType="pubmed">30168804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas D.D., Corkey B.E., Istfan N.W., Apovian C.M. Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction. J. Endocr. Soc. 2019;3:1727â1747. doi: 10.1210/js.2019-00065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/js.2019-00065</ArticleId>
            <ArticleId IdType="pmc">PMC6735759</ArticleId>
            <ArticleId IdType="pubmed">31528832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bazotte R.B., Silva L.G., Schiavon F.P. Insulin resistance in the liver: Deficiency or excess of insulin? Cell Cycle. 2014;13:2494â2500. doi: 10.4161/15384101.2014.947750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/15384101.2014.947750</ArticleId>
            <ArticleId IdType="pmc">PMC4612674</ArticleId>
            <ArticleId IdType="pubmed">25486190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santoleri D., Titchenell P.M. Resolving the Paradox of Hepatic Insulin Resistance. Cell. Mol. Gastroenterol. Hepatol. 2019;7:447â456. doi: 10.1016/j.jcmgh.2018.10.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcmgh.2018.10.016</ArticleId>
            <ArticleId IdType="pmc">PMC6369222</ArticleId>
            <ArticleId IdType="pubmed">30739869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Titchenell P.M., Quinn W.J., Lu M., Chu Q., Lu W., Li C., Chen H., Monks B.R., Chen J., Rabinowitz J.D., et al.  Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Cell Metab. 2016;23:1154â1166. doi: 10.1016/j.cmet.2016.04.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2016.04.022</ArticleId>
            <ArticleId IdType="pmc">PMC4909537</ArticleId>
            <ArticleId IdType="pubmed">27238637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects. Endocr. Rev. 1998;19:477â490. doi: 10.1210/edrv.19.4.0336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/edrv.19.4.0336</ArticleId>
            <ArticleId IdType="pubmed">9715376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woo V.C. New Insulins and New Aspects in Insulin Delivery. Can. J. Diabetes. 2015;39:335â343. doi: 10.1016/j.jcjd.2015.04.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcjd.2015.04.006</ArticleId>
            <ArticleId IdType="pubmed">26233724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Majeed W., Thabit H. Closed-loop insulin delivery: Current status of diabetes technologies and future prospects. Expert Rev. Med. Devices. 2018;15:579â590. doi: 10.1080/17434440.2018.1503530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17434440.2018.1503530</ArticleId>
            <ArticleId IdType="pubmed">30027775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramzy A., Mojibian M., Kieffer T.J. Insulin-Deficient Mouse beta-Cells Do Not Fully Mature but Can Be Remedied Through Insulin Replacement by Islet Transplantation. Endocrinology. 2018;159:83â102. doi: 10.1210/en.2017-00263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2017-00263</ArticleId>
            <ArticleId IdType="pubmed">29029025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maneschi F., Mashiter K., Kohner E.M. Insulin resistance and insulin deficiency in diabetic retinopathy of non-insulin-dependent diabetes. Diabetes. 1983;32:82â87. doi: 10.2337/diab.32.1.82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diab.32.1.82</ArticleId>
            <ArticleId IdType="pubmed">6336706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cerasi E. Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: Is a divorce possible? Diabetologia. 1995;38:992â997. doi: 10.1007/BF00400591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00400591</ArticleId>
            <ArticleId IdType="pubmed">7589888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groop L.C., Widen E., Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: Errors of metabolism or of methods? Diabetologia. 1993;36:1326â1331. doi: 10.1007/BF00400814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00400814</ArticleId>
            <ArticleId IdType="pubmed">8307264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuzuya T., Matsuda A. Classification of diabetes on the basis of etiologies versus degree of insulin deficiency. Diabetes Care. 1997;20:219â220. doi: 10.2337/diacare.20.2.219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.20.2.219</ArticleId>
            <ArticleId IdType="pubmed">9118778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moghetti P., Tosi F. Insulin resistance and PCOS: Chicken or egg? J. Endocrinol. Investig. 2021;44:233â244. doi: 10.1007/s40618-020-01351-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40618-020-01351-0</ArticleId>
            <ArticleId IdType="pubmed">32648001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas N.J., Lynam A.L., Hill A.V., Weedon M.N., Shields B.M., Oram R.A., McDonald T.J., Hattersley A.T., Jones A.G. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes. Diabetologia. 2019;62:1167â1172. doi: 10.1007/s00125-019-4863-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-019-4863-8</ArticleId>
            <ArticleId IdType="pmc">PMC6559997</ArticleId>
            <ArticleId IdType="pubmed">30969375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopp W. How Western Diet and Lifestyle Drive the Pandemic of Obesity and Civilization Diseases. Diabetes Metab. Syndr. Obes. 2019;12:2221â2236. doi: 10.2147/DMSO.S216791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/DMSO.S216791</ArticleId>
            <ArticleId IdType="pmc">PMC6817492</ArticleId>
            <ArticleId IdType="pubmed">31695465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jezek P., Jaburek M., Holendova B., Plecita-Hlavata L. Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity. Molecules. 2018:23.</Citation>
        </Reference>
        <Reference>
          <Citation>Jia G., Whaley-Connell A., Sowers J.R. Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61:21â28. doi: 10.1007/s00125-017-4390-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-017-4390-4</ArticleId>
            <ArticleId IdType="pmc">PMC5720913</ArticleId>
            <ArticleId IdType="pubmed">28776083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otto-Buczkowska E., Grzyb K., Jainta N. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty. Pediatr. Endocrinol. Diabetes Metab. 2018;24:40â44. doi: 10.18544/PEDM-24.01.0101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18544/PEDM-24.01.0101</ArticleId>
            <ArticleId IdType="pubmed">30083660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerich J.E. Control of glycaemia. Baillieres Clin. Endocrinol. Metab. 1993;7:551â586. doi: 10.1016/S0950-351X(05)80207-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0950-351X(05)80207-1</ArticleId>
            <ArticleId IdType="pubmed">8379904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villegas-Valverde C.C., Kokuina E., Breff-Fonseca M.C. Strengthening National Health Priorities for Diabetes Prevention and Management. MEDICC Rev. 2018;20:5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31242164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammer M., Storey S., Hershey D.S., Brady V.J., Davis E., Mandolfo N., Bryant A.L., Olausson J. Hyperglycemia and Cancer: A State-of-the-Science Review. Oncol. Nurs. Forum. 2019;46:459â472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31225836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giugliano D., Ceriello A., Esposito K. Glucose metabolism and hyperglycemia. Am. J. Clin. Nutr. 2008;87:217Sâ222S. doi: 10.1093/ajcn/87.1.217S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ajcn/87.1.217S</ArticleId>
            <ArticleId IdType="pubmed">18175761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rawlings A.M., Sharrett A.R., Albert M.S., Coresh J., Windham B.G., Power M.C., Knopman D.S., Walker K., Burgard S., Mosley T.H., et al.  The Association of Late-Life Diabetes Status and Hyperglycemia with Incident Mild Cognitive Impairment and Dementia: The ARIC Study. Diabetes Care. 2019;42:1248â1254. doi: 10.2337/dc19-0120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc19-0120</ArticleId>
            <ArticleId IdType="pmc">PMC6609963</ArticleId>
            <ArticleId IdType="pubmed">31221696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobsen J.J., Black M.H., Li B.H., Reynolds K., Lawrence J.M. Race/ethnicity and measures of glycaemia in the year after diagnosis among youth with type 1 and type 2 diabetes mellitus. J. Diabetes Complicat. 2014;28:279â285. doi: 10.1016/j.jdiacomp.2014.01.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jdiacomp.2014.01.010</ArticleId>
            <ArticleId IdType="pubmed">24581944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yari Z., Behrouz V., Zand H., Pourvali K. New Insight into Diabetes Management: From Glycemic Index to Dietary Insulin Index. Curr. Diabetes Rev. 2020;16:293â300. doi: 10.2174/1573399815666190614122626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1573399815666190614122626</ArticleId>
            <ArticleId IdType="pubmed">31203801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon K., Wittmann I. Can blood glucose value really be referred to as a metabolic parameter? Rev. Endocr. Metab. Disord. 2019;20:151â160. doi: 10.1007/s11154-019-09504-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11154-019-09504-0</ArticleId>
            <ArticleId IdType="pmc">PMC6556155</ArticleId>
            <ArticleId IdType="pubmed">31089886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garber A.J., Cryer P.E., Santiago J.V., Haymond M.W., Pagliara A.S., Kipnis D.M. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Investig. 1976;58:7â15. doi: 10.1172/JCI108460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI108460</ArticleId>
            <ArticleId IdType="pmc">PMC333149</ArticleId>
            <ArticleId IdType="pubmed">6491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coutinho M., Gerstein H.C., Wang Y., Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233â240. doi: 10.2337/diacare.22.2.233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.22.2.233</ArticleId>
            <ArticleId IdType="pubmed">10333939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Decode Study Group. European Diabetes Epidemiology Group  Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care. 2003;26:688â696. doi: 10.2337/diacare.26.3.688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.26.3.688</ArticleId>
            <ArticleId IdType="pubmed">12610023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gosmanov A.R., Gosmanova E.O., Kitabchi A.E.  Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. In: Feingold K.R., Anawalt B., Boyce A., Chrousos G., de Herder W.W., Dhatariya K., Dungan K., Grossman A., Hershman J.M., Hofland J., et al., editors. Endotext. MDText.com, Inc.; South Dartmouth, MA, USA: 2000. </Citation>
        </Reference>
        <Reference>
          <Citation>Rahman M.S., Adegoke E.O., Pang M.G. Drivers of owning more BPA. J. Hazard. Mater. 2021;417:126076. doi: 10.1016/j.jhazmat.2021.126076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhazmat.2021.126076</ArticleId>
            <ArticleId IdType="pubmed">34004580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esposito K., Giugliano D. Diet and inflammation: A link to metabolic and cardiovascular diseases. Eur. Heart J. 2006;27:15â20. doi: 10.1093/eurheartj/ehi605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehi605</ArticleId>
            <ArticleId IdType="pubmed">16219650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gorska E., Popko K., Stelmaszczyk-Emmel A., Ciepiela O., Kucharska A., Wasik M. Leptin receptors. Eur. J. Med. Res. 2010;15(Suppl. 2):50â54. doi: 10.1186/2047-783X-15-S2-50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/2047-783X-15-S2-50</ArticleId>
            <ArticleId IdType="pmc">PMC4360333</ArticleId>
            <ArticleId IdType="pubmed">21147620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marroqui L., Gonzalez A., Neco P., Caballero-Garrido E., Vieira E., Ripoll C., Nadal A., Quesada I. Role of leptin in the pancreatic beta-cell: Effects and signaling pathways. J. Mol. Endocrinol. 2012;49:R9âR17. doi: 10.1530/JME-12-0025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/JME-12-0025</ArticleId>
            <ArticleId IdType="pubmed">22448029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lumeng C.N., Saltiel A.R. Inflammatory links between obesity and metabolic disease. J. Clin. Investig. 2011;121:2111â2117. doi: 10.1172/JCI57132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI57132</ArticleId>
            <ArticleId IdType="pmc">PMC3104776</ArticleId>
            <ArticleId IdType="pubmed">21633179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khodabandehloo H., Gorgani-Firuzjaee S., Panahi G., Meshkani R. Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction. Transl. Res. 2016;167:228â256. doi: 10.1016/j.trsl.2015.08.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trsl.2015.08.011</ArticleId>
            <ArticleId IdType="pubmed">26408801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boni-Schnetzler M., Boller S., Debray S., Bouzakri K., Meier D.T., Prazak R., Kerr-Conte J., Pattou F., Ehses J.A., Schuit F.C., et al.  Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology. 2009;150:5218â5229. doi: 10.1210/en.2009-0543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2009-0543</ArticleId>
            <ArticleId IdType="pubmed">19819943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang C., Naassan A.E., Chamson-Reig A., Koulajian K., Goh T.T., Yoon F., Oprescu A.I., Ghanim H., Lewis G.F., Dandona P., et al.  Susceptibility to fatty acid-induced beta-cell dysfunction is enhanced in prediabetic diabetes-prone biobreeding rats: A potential link between beta-cell lipotoxicity and islet inflammation. Endocrinology. 2013;154:89â101. doi: 10.1210/en.2012-1720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2012-1720</ArticleId>
            <ArticleId IdType="pubmed">23150493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGarry J.D., Dobbins R.L. Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 1999;42:128â138. doi: 10.1007/s001250051130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s001250051130</ArticleId>
            <ArticleId IdType="pubmed">10064091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boden G., Shulman G.I. Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Investig. 2002;32(Suppl. 3):14â23. doi: 10.1046/j.1365-2362.32.s3.3.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2362.32.s3.3.x</ArticleId>
            <ArticleId IdType="pubmed">12028371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimabukuro M., Wang M.Y., Zhou Y.T., Newgard C.B., Unger R.H. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc. Natl. Acad. Sci. USA. 1998;95:9558â9561. doi: 10.1073/pnas.95.16.9558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.95.16.9558</ArticleId>
            <ArticleId IdType="pmc">PMC21377</ArticleId>
            <ArticleId IdType="pubmed">9689119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gravena C., Mathias P.C., Ashcroft S.J. Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. J. Endocrinol. 2002;173:73â80. doi: 10.1677/joe.0.1730073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1677/joe.0.1730073</ArticleId>
            <ArticleId IdType="pubmed">11927386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamashita T., Eto K., Okazaki Y., Yamashita S., Yamauchi T., Sekine N., Nagai R., Noda M., Kadowaki T. Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a beta-cell lipotoxicity model overexpressing sterol regulatory element-binding protein-1c. Endocrinology. 2004;145:3566â3577. doi: 10.1210/en.2003-1602.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2003-1602</ArticleId>
            <ArticleId IdType="pubmed">15059954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joseph J.W., Koshkin V., Saleh M.C., Sivitz W.I., Zhang C.Y., Lowell B.B., Chan C.B., Wheeler M.B. Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J. Biol. Chem. 2004;279:51049â51056. doi: 10.1074/jbc.M409189200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M409189200</ArticleId>
            <ArticleId IdType="pubmed">15448158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupi R., Dotta F., Marselli L., Del Guerra S., Masini M., Santangelo C., Patane G., Boggi U., Piro S., Anello M., et al.  Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes. 2002;51:1437â1442. doi: 10.2337/diabetes.51.5.1437.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.51.5.1437</ArticleId>
            <ArticleId IdType="pubmed">11978640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poitout V., Robertson R.P. Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocr. Rev. 2008;29:351â366. doi: 10.1210/er.2007-0023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2007-0023</ArticleId>
            <ArticleId IdType="pmc">PMC2528858</ArticleId>
            <ArticleId IdType="pubmed">18048763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan Q., Lu X., Zhao C., Liao S., Chen X., Guo F., Yang C., Liu H.F. Metformin: The updated protective property in kidney disease. Aging. 2020;12:8742â8759. doi: 10.18632/aging.103095.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/aging.103095</ArticleId>
            <ArticleId IdType="pmc">PMC7244070</ArticleId>
            <ArticleId IdType="pubmed">32364526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou T., Xu X., Du M., Zhao T., Wang J. A preclinical overview of metformin for the treatment of type 2 diabetes. Biomed. Pharmacother. 2018;106:1227â1235. doi: 10.1016/j.biopha.2018.07.085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2018.07.085</ArticleId>
            <ArticleId IdType="pubmed">30119191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., Zinman B. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193â203. doi: 10.2337/dc08-9025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc08-9025</ArticleId>
            <ArticleId IdType="pmc">PMC2606813</ArticleId>
            <ArticleId IdType="pubmed">18945920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whalen K., Miller S., Onge E.S. The Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Treatment of Type 2 Diabetes. Clin. Ther. 2015;37:1150â1166. doi: 10.1016/j.clinthera.2015.03.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinthera.2015.03.004</ArticleId>
            <ArticleId IdType="pubmed">25891804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soccio R.E., Chen E.R., Lazar M.A. Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes. Cell Metab. 2014;20:573â591. doi: 10.1016/j.cmet.2014.08.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2014.08.005</ArticleId>
            <ArticleId IdType="pmc">PMC4192012</ArticleId>
            <ArticleId IdType="pubmed">25242225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Usman B., Sharma N., Satija S., Mehta M., Vyas M., Khatik G.L., Khurana N., Hansbro P.M., Williams K., Dua K. Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update. Curr. Pharm. Des. 2019;25:2510â2525. doi: 10.2174/1381612825666190717104547.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1381612825666190717104547</ArticleId>
            <ArticleId IdType="pubmed">31333110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Den Hartogh D.J., Tsiani E. Health Benefits of Resveratrol in Kidney Disease: Evidence from In Vitro and In Vivo Studies. Nutrients. 2019;11:1624.  doi: 10.3390/nu11071624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nu11071624</ArticleId>
            <ArticleId IdType="pmc">PMC6682908</ArticleId>
            <ArticleId IdType="pubmed">31319485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji H., Wu L., Ma X., Ma X., Qin G. The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy. Mol. Biol. Rep. 2014;41:2151â2159. doi: 10.1007/s11033-014-3064-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11033-014-3064-2</ArticleId>
            <ArticleId IdType="pubmed">24413998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang S.C., Hsu C.Y., Chou W.L., Fang J.Y., Chuang S.Y. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model. Molecules. 2020;25:5713.  doi: 10.3390/molecules25235713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules25235713</ArticleId>
            <ArticleId IdType="pmc">PMC7731446</ArticleId>
            <ArticleId IdType="pubmed">33287318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garud M.S., Kulkarni Y.A. Gallic acid attenuates type I diabetic nephropathy in rats. Chem. Biol. Interact. 2018;282:69â76. doi: 10.1016/j.cbi.2018.01.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cbi.2018.01.010</ArticleId>
            <ArticleId IdType="pubmed">29331653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du S.Y., Liu H.R., Lei T.T., Xie X.F., Wang H.L., He X., Tong R.S., Wang Y. Mangiferin: An effective therapeutic agent against several disorders. Mol. Med. Rep. 2018;18:4775â4786. doi: 10.3892/mmr.2018.9529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2018.9529</ArticleId>
            <ArticleId IdType="pubmed">30280187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yen F.S., Wei J.C., Lin M.C., Hsu C.C., Hwu C.M. Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes. BMC Endocr. Disord. 2021;21:25.  doi: 10.1186/s12902-021-00690-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12902-021-00690-0</ArticleId>
            <ArticleId IdType="pmc">PMC7890630</ArticleId>
            <ArticleId IdType="pubmed">33602190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanaujia A., Duggar R., Pannakal S.T., Yadav S.S., Katiyar C.K., Bansal V., Anand S., Sujatha S., Lakshmi B.S. Insulinomimetic activity of two new gallotannins from the fruits of Capparis moonii. Bioorg. Med. Chem. 2010;18:3940â3945. doi: 10.1016/j.bmc.2010.04.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmc.2010.04.032</ArticleId>
            <ArticleId IdType="pubmed">20452777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jose T., Inzucchi S.E. Cardiovascular effects of the DPP-4 inhibitors. Diabetes Vasc. Dis. Res. 2012;9:109â116. doi: 10.1177/1479164111436236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1479164111436236</ArticleId>
            <ArticleId IdType="pubmed">22337893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Shafey E.S., Elsherbiny E.S. The role of apoptosis and autophagy in the insulin-enhancing activity of oxovanadium(IV) bipyridine complex in streptozotocin-induced diabetic mice. Biometals. 2020;33:123â135. doi: 10.1007/s10534-020-00237-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10534-020-00237-1</ArticleId>
            <ArticleId IdType="pubmed">32318895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasouli H., Yarani R., Pociot F., Popovic-Djordjevic J. Anti-diabetic potential of plant alkaloids: Revisiting current findings and future perspectives. Pharmacol. Res. 2020;155:104723. doi: 10.1016/j.phrs.2020.104723.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.phrs.2020.104723</ArticleId>
            <ArticleId IdType="pubmed">32105756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar Y., Thakur A.K., Goyal R.K. Evaluation of Alpha Glucosidase Inhibitor (Miglitol) for its Efficacy in Constipation Associated with Diabetes. Indian J. Pharm. Educ. 2019;53:S387âS391. doi: 10.5530/ijper.53.3s.110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5530/ijper.53.3s.110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feingold K.R.  Oral and Injectable (Non-Insulin) Pharmacological Agents for Type 2 Diabetes. In: Feingold K.R., Anawalt B., Boyce A., Chrousos G., de Herder W.W., Dhatariya K., Dungan K., Grossman A., Hershman J.M., Hofland J., et al., editors. Endotext. MDText.com, Inc.; South Dartmouth, MA, USA: 2000. </Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
